ZFP57-related Transient Neonatal Diabetes Responsive to Oral Sulfonylurea Treatment

Klin Padiatr. 2019 Jul;231(4):225-226. doi: 10.1055/a-0889-8307. Epub 2019 May 7.

Authors

Christina Reinauer¹, Carsten Bergmann², Annemarie Jonasson², Volker Soditt³, Ertan Mayatepek¹, Thomas Meißner¹, Sebastian Kummer¹

Affiliations

¹ Department of General Pediatrics, University Children's Hospital Duesseldorf, Duesseldorf.
² Center for Human Genetics, Bioscientia Ingelheim, Ingelheim.
³ Department of Pediatrics, Solingen Municipal Hospital, Solingen.

PMID: 31064016
DOI: 10.1055/a-0889-8307

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
DNA-Binding Proteins / genetics*
Diabetes Mellitus / diagnosis
Diabetes Mellitus / drug therapy*
Humans
Infant, Newborn
Infant, Newborn, Diseases
Mutation
Repressor Proteins
Sulfonylurea Compounds / administration & dosage*
Sulfonylurea Compounds / therapeutic use
Transcription Factors / genetics*

Substances

DNA-Binding Proteins
Repressor Proteins
Sulfonylurea Compounds
Transcription Factors
ZFP57 protein, human